Therapeutic cell death induced protected from chemotherapy induced. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Mesenchymal Stromal Cells Cell Line, Tumor Mitochondria Cells, Cultured Tumor Cells, Cultured Cell Line Neurons Jurkat Cells HeLa Cells Cell Nucleus

Organisms4

Mice, Inbred C57BL Mice, Nude Mice, Knockout Rats, Sprague-Dawley

Diseases51

Death Breast Neoplasms Lung Neoplasms Necrosis Neoplasms Neoplasm Recurrence, Local Death, Sudden, Cardiac Carcinoma, Non-Small-Cell Lung Ovarian Neoplasms Adenocarcinoma Neoplasm Metastasis Brain Death Testicular Neoplasms Colorectal Neoplasms Lymphoma, Non-Hodgkin Neutropenia Vomiting Hodgkin Disease Nausea Brain Neoplasms Liver Neoplasms Osteosarcoma Fetal Death Bone Neoplasms Neoplasms, Germ Cell and Embryonal Recurrence Disease Progression Stomach Neoplasms Leukopenia Carcinoma Carcinoma, Squamous Cell Peritoneal Neoplasms Lymphoma Lymphatic Metastasis Precursor Cell Lymphoblastic Leukemia-Lymphoma Germinoma Leukemia, Myeloid, Acute Colonic Neoplasms Thrombocytopenia Disease Models, Animal Head and Neck Neoplasms Sarcoma Neuroblastoma Pancreatic Neoplasms Glioma Leukemia Lymphoma, Large B-Cell, Diffuse Multiple Myeloma Neoplasm, Residual Leukemia, Myeloid Retroperitoneal Neoplasms

Chemicals and Drugs86

Antineoplastic Agents Cisplatin Doxorubicin Cyclophosphamide Caspases Etoposide Caspase 3 Proto-Oncogene Proteins c-bcl-2 Paclitaxel Methotrexate Carboplatin Vinblastine Taxoids Ifosfamide Antimetabolites, Antineoplastic Antineoplastic Agents, Phytogenic Bleomycin Deoxycytidine Organoplatinum Compounds bcl-2-Associated X Protein Antineoplastic Agents, Alkylating Caspase Inhibitors Anthracyclines Reactive Oxygen Species Cytarabine Antigens, CD95 Antibiotics, Antineoplastic Apoptosis Regulatory Proteins Tumor Suppressor Protein p53 Camptothecin Poly(ADP-ribose) Polymerases Amino Acid Chloromethyl Ketones Dacarbazine Caspase 8 Cytochromes c Caspase 9 Carmustine Cysteine Proteinase Inhibitors Fas Ligand Protein bcl-X Protein Granulocyte Colony-Stimulating Factor Tumor Markers, Biological Mitomycin Lomustine Proto-Oncogene Proteins Enzyme Inhibitors Platinum Compounds Melphalan Antibodies, Monoclonal Mitoxantrone RNA, Small Interfering Antiemetics Thiotepa Antibodies, Monoclonal, Humanized Daunorubicin Tegafur Recombinant Proteins Receptors, Death Domain Apoptosis Inducing Factor Hydrogen Peroxide RNA, Messenger Bridged Compounds Annexin A5 Inhibitor of Apoptosis Proteins Platinum Vindesine bcl-2 Homologous Antagonist-Killer Protein Dexamethasone BH3 Interacting Domain Death Agonist Protein Neoplasm Proteins Tumor Necrosis Factor-alpha Membrane Proteins DNA-Binding Proteins Receptor, erbB-2 Oxonic Acid Antibodies, Monoclonal, Murine-Derived Caspase 7 Receptors, Estrogen Tamoxifen Caspase 1 Prednisolone Propidium Carrier Proteins Neuroprotective Agents Cysteine Endopeptidases Membrane Glycoproteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment52

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Cause of Death Combined Modality Therapy Treatment Outcome Neoadjuvant Therapy Survival Analysis Disease-Free Survival Prognosis Survival Rate Neoplasm Staging Drug Administration Schedule Induction Chemotherapy Follow-Up Studies In Situ Nick-End Labeling Prospective Studies Chemotherapy, Cancer, Regional Perfusion Salvage Therapy Kaplan-Meier Estimate Transplantation, Autologous Radiotherapy, Adjuvant Immunohistochemistry Radiotherapy Clinical Trials as Topic Blotting, Western Risk Factors Flow Cytometry Palliative Care Infusions, Intra-Arterial Drug Therapy Infusions, Intravenous Hematopoietic Stem Cell Transplantation Models, Biological Randomized Controlled Trials as Topic Multivariate Analysis Transfection Radiotherapy Dosage Drug Screening Assays, Antitumor Hyperthermia, Induced Xenograft Model Antitumor Assays Reverse Transcriptase Polymerase Chain Reaction Disease Models, Animal Chemoradiotherapy Fatal Outcome Actuarial Analysis Cohort Studies Maintenance Chemotherapy Feasibility Studies Clinical Trials, Phase III as Topic Cranial Irradiation Bone Marrow Transplantation Risk Assessment

Psychiatry and Psychology1

Attitude to Death

Phenomena and Processes28

Cell Death Apoptosis Cell Survival Time Factors Necrosis Drug Resistance, Neoplasm DNA Fragmentation Signal Transduction Autophagy Dose-Response Relationship, Drug Enzyme Activation Cell Proliferation Mutation DNA Damage Membrane Potential, Mitochondrial Drug Synergism Cell Cycle Gene Expression Regulation, Neoplastic Transfection Oxidative Stress Cell Division Cytoprotection Genes, bcl-2 Down-Regulation RNA Interference Up-Regulation Phosphorylation Gene Expression

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science4

Cause of Death Survival Rate Fatal Outcome Molecular Sequence Data

Health Care21

Cause of Death Treatment Outcome Survival Analysis Disease-Free Survival Survival Rate Follow-Up Studies Prospective Studies Kaplan-Meier Estimate Clinical Trials as Topic Risk Factors Palliative Care Attitude to Death Randomized Controlled Trials as Topic Multivariate Analysis Age Factors Fatal Outcome Actuarial Analysis Cohort Studies Feasibility Studies Clinical Trials, Phase III as Topic Risk Assessment

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Mesenchymal Stromal Cells Cell Death Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Apoptosis Cause of Death Antineoplastic Agents Cisplatin Combined Modality Therapy Doxorubicin Treatment Outcome Cyclophosphamide Caspases Death Cell Survival Etoposide Breast Neoplasms Neoadjuvant Therapy Survival Analysis Disease-Free Survival Prognosis Survival Rate Neoplasm Staging Cell Line, Tumor Lung Neoplasms Time Factors Necrosis Neoplasms Drug Administration Schedule Caspase 3 Proto-Oncogene Proteins c-bcl-2 Paclitaxel Methotrexate Drug Resistance, Neoplasm Carboplatin Vinblastine DNA Fragmentation Induction Chemotherapy Taxoids Signal Transduction Neoplasm Recurrence, Local Mitochondria Follow-Up Studies Autophagy Dose-Response Relationship, Drug Ifosfamide Antimetabolites, Antineoplastic Antineoplastic Agents, Phytogenic Bleomycin In Situ Nick-End Labeling Deoxycytidine Organoplatinum Compounds bcl-2-Associated X Protein Antineoplastic Agents, Alkylating Caspase Inhibitors Death, Sudden, Cardiac Cells, Cultured Anthracyclines Reactive Oxygen Species Cytarabine Carcinoma, Non-Small-Cell Lung Ovarian Neoplasms Antigens, CD95 Prospective Studies Adenocarcinoma Chemotherapy, Cancer, Regional Perfusion Neoplasm Metastasis Salvage Therapy Tumor Cells, Cultured Antibiotics, Antineoplastic Brain Death Apoptosis Regulatory Proteins Tumor Suppressor Protein p53 Testicular Neoplasms Kaplan-Meier Estimate Colorectal Neoplasms Cell Line Lymphoma, Non-Hodgkin Neutropenia Transplantation, Autologous Vomiting Enzyme Activation Hodgkin Disease Radiotherapy, Adjuvant Nausea Brain Neoplasms Camptothecin Poly(ADP-ribose) Polymerases Immunohistochemistry Amino Acid Chloromethyl Ketones Radiotherapy Dacarbazine Clinical Trials as Topic Neurons Caspase 8 Cytochromes c Liver Neoplasms Osteosarcoma Cell Proliferation Blotting, Western

No FAQ available that match "therapeutic cell death induced protected from chemotherapy induced"